Back
Supernus Pharmaceuticals Vs. Lantheus Holdings Industry Stock Comparison
Buy
51
SUPN
Supernus Pharmaceuticals
Last Price:
37.26
Seasonality Move:
8.24%
Sell
18
LNTH
Lantheus Holdings
Last Price:
91.59
Seasonality Move:
-1.72%
Buy
51
Supernus Pharmaceuticals (SUPN)
is a Buy
Is Supernus Pharmaceuticals a Buy, Sell or Hold?
- The current Supernus Pharmaceuticals [SUPN] share price is $37.75. The Score for SUPN is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- SUPN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
18
Lantheus Holdings (LNTH)
is a Sell
Is Lantheus Holdings a Buy, Sell or Hold?
- The current Lantheus Holdings [LNTH] share price is $91.13. The Score for LNTH is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
- LNTH is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
SUPN Stock Price Chart
What is Supernus Pharmaceuticals's stock price today?
-
The Supernus Pharmaceuticals share price today is $37.75
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SUPN is experiencing buying pressure, which is a positive indicator for future bullish movement.
LNTH Stock Price Chart
What is Lantheus Holdings's stock price today?
-
The Lantheus Holdings share price today is $91.13
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LNTH is experiencing slight selling pressure.
SUPN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.83 | Buy |
| Relative Strength Index (14 RSI): | 76.85 | Buy |
| Chaikin Money Flow: | 420499 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.37 - 34.89) | Buy |
| Bollinger Bands (100): | (28.44 - 34.28) | Buy |
LNTH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.5 | Sell |
| Relative Strength Index (14 RSI): | 29.37 | Sell |
| Chaikin Money Flow: | -2309062 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (104.96 - 114.28) | Sell |
| Bollinger Bands (100): | (91.07 - 114.93) | Sell |
SUPN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 34.84 | Buy |
| 20-day SMA: | 34 | Buy |
| 50-day SMA: | 33.09 | Buy |
| 200-day SMA: | 30.61 | Buy |
| 8-day EMA: | 35.11 | Buy |
| 20-day EMA: | 34.16 | Buy |
| 50-day EMA: | 33.11 | Buy |
| 200-day EMA: | 31.13 | Buy |
LNTH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 108.62 | Sell |
| 20-day SMA: | 110.31 | Sell |
| 50-day SMA: | 107.99 | Sell |
| 200-day SMA: | 84.39 | Buy |
| 8-day EMA: | 107.29 | Sell |
| 20-day EMA: | 108.9 | Sell |
| 50-day EMA: | 107.18 | Sell |
| 200-day EMA: | 91.45 | Sell |
Supernus Pharmaceuticals Earnings Growth & SUPN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.87 per share, and a decrease next year of $0.96 per share.
Lantheus Holdings Earnings Growth & LNTH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.80 per share, and an increase next year of $0.43 per share.
Supernus Pharmaceuticals Technical Analysis
| Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Lantheus Holdings Technical Analysis
| Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||